S
Shiji Fang
H指数:26
被引数:2,419
浏览量:0
个人简介
暂无内容
教育背景
暂无内容
工作经历
暂无内容
荣誉奖项
暂无内容
Impact of Proximal Stent Placement Site on Postoperative Outcomes After TIPS: Hepatic Vein Versus Inferior Vena Cava
经颈静脉肝内门体分流术后近端支架放置位置对术后结局的影响:肝静脉与下腔静脉的比较
Academic Radiology
IF3.9
Mitochondria-Targeted Nanomotor: H2S-Driven Cascade Therapy for Hepatocellular Carcinoma
线粒体靶向纳米马达:H2S驱动的级联疗法用于肝细胞癌
ADVANCED MATERIALS
IF26.8
Tumor-Targeted FABP5/STING Cascade Promote Radiofrequency Ablation Induced Ferroptosis and Intratumoral Immune Rewiring in Hepatocellular Carcinoma
肿瘤靶向FABP5/STING级联促进射频消融诱导的铁死亡及肝癌内的肿瘤内免疫重编程
Advanced Science
IF14.1
Magnesium microspheres for enhanced transarterial chemoembolization therapy of hepatocellular carcinoma: From animal models to a pilot clinical study
用于增强经动脉化疗栓塞治疗肝细胞癌的镁微球:从动物模型到一项初步临床研究
Science Advances
IF12.5
Lactate-Fueled Theranostic Nanoplatforms for Enhanced MRI-Guided Ferroptosis Synergistic with Immunotherapy of Hepatocellular Carcinoma
乳酸供能的诊疗一体化纳米平台,用于增强MRI引导的 ferroptosis 与免疫治疗协同作用的肝细胞癌治疗
MELK prevents radiofrequency ablation-induced immunogenic cell death and antitumor immune response by stabilizing FABP5 in hepatocellular malignancies
MELK通过稳定FABP5,抑制射频消融诱导的免疫原性细胞死亡及抗肿瘤免疫反应,从而在肝细胞恶性肿瘤中发挥作用。
Cuproptosis, ferroptosis and PANoptosis in tumor immune microenvironment remodeling and immunotherapy: culprits or new hope
肿瘤免疫微环境重塑和免疫治疗中的Cuproptosis,ferroptosis和PANoptosis: 罪魁祸首或新希望
MOLECULAR CANCER
IF33.9
Mesenchymal stem cell-derived extracellular vesicles in skin wound healing: roles, opportunities and challenges
间充质干细胞来源的细胞外囊泡在皮肤创伤愈合中的作用、机遇与挑战

